These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11976440)

  • 21. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
    Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
    J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Special antibodies for the study of systemic lupus erythematosus: an analysis.
    Tan EM
    Arthritis Rheum; 1982 Jul; 25(7):753-6. PubMed ID: 6980650
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genetic association of autoantibodies against recombinant antigens of the ENA group and cardiolipin in systemic lupus erythematosus (SLE)].
    Hartung K; Renz M; Ehrfeld H; Deicher H; Seelig HP
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):491-4. PubMed ID: 7856250
    [No Abstract]   [Full Text] [Related]  

  • 24. Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
    Rahman A; Stollar BD
    Lupus; 2008 Mar; 17(3):232-5. PubMed ID: 18372367
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus.
    Flores RH; Stevens MB; Arnett FC
    J Rheumatol; 1984 Jun; 11(3):321-3. PubMed ID: 6610754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.
    Eisenberg RA
    Springer Semin Immunopathol; 1992; 14(2):127-39. PubMed ID: 1475740
    [No Abstract]   [Full Text] [Related]  

  • 27. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical course of patients with anti-RNP antibodies.
    Snowden N; Hay E; Holt PJ; Bernstein R
    J Rheumatol; 1993 Jul; 20(7):1256-8. PubMed ID: 8371236
    [No Abstract]   [Full Text] [Related]  

  • 29. Obtention of Sm antigen from L5178 murine lymphoma malignant cells.
    Lamas-Robles C; Mejía-Arreguín S; Gómez-Estrada H; González-Mendoza A
    Arch Invest Med (Mex); 1984; 15(3):259-65. PubMed ID: 6443059
    [No Abstract]   [Full Text] [Related]  

  • 30. New diagnostic test for lupus.
    Dorrell S
    Mol Med Today; 2000 Nov; 6(11):412-3. PubMed ID: 11074360
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
    Tsao BP; Grossman JM; Riemekasten G; Strong N; Kalsi J; Wallace DJ; Chen CJ; Lau CS; Ginzler EM; Goldstein R; Kalunian KC; Harley JB; Arnett FC; Hahn BH; Cantor RM
    Arthritis Rheum; 2002 Oct; 46(10):2678-85. PubMed ID: 12384927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinuclear antibodies in the immunotaxonomy of connective tissue diseases.
    Maini RN; Charles PJ; Venables PJ
    Scand J Rheumatol Suppl; 1985; 56():49-57. PubMed ID: 3873689
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-based immunotherapy of systemic lupus erythematosus.
    Monneaux F; Muller S
    Autoimmun Rev; 2004 Jan; 3(1):16-24. PubMed ID: 14871645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function.
    Kyttaris VC; Krishnan S; Tsokos GC
    Autoimmunity; 2006 Dec; 39(8):705-9. PubMed ID: 17178567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular aspects in the pathogenesis of human systemic lupus erythematosus.
    Liossis SN; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):11-9. PubMed ID: 10722226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antinuclear antibodies].
    Pigrau-Serrallach C; Guardia-Massó J
    Med Clin (Barc); 1983 May; 80(19):850-8. PubMed ID: 6193377
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary and update: serological tests for diagnosis of systemic lupus erythematosus (SLE).
    Clough JD; Calabrese LH
    Cleve Clin Q; 1983; 50(2):65-8. PubMed ID: 6196142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.